|Articles|October 1, 2000

October 2000
Volume 6
Issue 10

Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

Author(s)Chester B. Good, MD, MPH, Shawn L. Fultz, MD, Lauren Trilli, PharmD

Download PDF: Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

Articles in this issue

almost 26 years ago

Article

A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

almost 26 years ago

Article

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

almost 26 years ago

Article

Accrediting Organizations and Quality Improvement

almost 26 years ago

Article

Efficient Evaluation of Thyroid Nodules by Primary Care Providers and Thyroid Specialists

almost 26 years ago

Article

Diagnosis of Skin Disease by Nondermatologists

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

Dietary Risks Tied to Rising Global CKD Burden

Racism, Abuse Linked to Higher Heart Failure Risk in Black Women

Confronting the "Urgency Gap" Between HFrEF and HFpEF Care

Closing the Gap: Innovation vs Access in Blood Cancer Care